View Older Stories View More Recent Stories

Feb 15, 2022 07:00AM Salix Announces 2022 Gastrointestinal Health Scholars Program
Feb 3, 2022 07:00AM Bausch Health Companies Inc. Will Release Fourth-Quarter and Full-Year 2021 Financial Results on February 23
Feb 1, 2022 06:59AM BAUSCH + LOMB AND PREVENT BLINDNESS LAUNCH ANNUAL AMD AWARENESS MONTH CAMPAIGN TO EDUCATE PATIENTS
Jan 20, 2022 07:07AM Bausch Health (BHC) Announces Dr. Yehia Hashad Will Join Bausch + Lomb Corporation as Executive Vice President of Research & Development and Chief Medical Officer
Jan 20, 2022 07:00AM Dr. Yehia Hashad Will Join Bausch + Lomb Corporation as Executive Vice President of Research & Development and Chief Medical Officer
Jan 11, 2022 07:00AM Bausch Health Will Provide Business And Strategic Update At The 40th Annual J.P. Morgan Healthcare Conference
Jan 5, 2022 07:00AM BAUSCH HEALTH TO PARTICIPATE AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Jan 4, 2022 06:59AM NEW SURVEY FROM BAUSCH + LOMB AND GLAUCOMA RESEARCH FOUNDATION REVEALS EMOTIONAL AND SOCIAL IMPACT OF HYPEREMIA ON GLAUCOMA PATIENTS
Dec 22, 2021 07:00AM RELISTOR® (METHYLNALTREXONE BROMIDE) DATA IS PUBLISHED IN THE JOURNAL OF EMERGENCY MEDICINE
Dec 6, 2021 06:59AM Bausch Health (BHC) Announces APMA Grants Seal of Approval for JUBLIA (efinaconazole) Topical Solution, 10%
Dec 6, 2021 06:59AM APMA Grants Seal of Approval for JUBLIA® (efinaconazole) Topical Solution, 10%
Dec 3, 2021 07:00AM Salix Brings Educational Resources on Constipation Into the Homes of Patients and Caregivers for Constipation Awareness Month
Nov 15, 2021 06:59AM Bausch + Lomb Reports More Than 41 Million Units Of Contact Lens, Eye And Lens Care Materials Recycled Through ONE By ONE And Biotrue® Eye Care Recycling Programs
Nov 11, 2021 07:00AM Salix Will Share New Rifaximin Data At AASLD's The Liver Meeting™ 2021
Nov 4, 2021 07:00AM Bausch Health Announces Participation In Upcoming Investor Conferences
Nov 2, 2021 06:59AM Bausch Health Companies Inc. Announces Third-Quarter 2021 Results
Nov 1, 2021 07:00AM Bausch + Lomb Will Present Scientific Data and Analyses During the American Academy of Ophthalmology and American Academy of Optometry Annual Meetings
Oct 27, 2021 06:59AM Bausch + Lomb Launches Biotrue® Eye Care Recycling Program in Collaboration With TerraCycle in the United States
Oct 25, 2021 08:00AM New Report Reveals Barriers To Quality Care For Chronic Liver Disease Patients, A Cause Of Morbidity And Mortality Projected To Grow In The United States
Oct 25, 2021 07:00AM Salix Will Feature New Data At The American College Of Gastroenterology® 2021 Annual Scientific Meeting
Oct 25, 2021 06:45AM Bausch + Lomb (BHC) and Clearside Biomedical Announce FDA Approval of XIPERE for Suprachoroidal Use for Treatment of Macular Edema Associated with Uveitis
Oct 25, 2021 06:45AM Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE™ (triamcinolone acetonide injectable suspension) for Suprachoroidal Use for the Treatment of Macular Edema Associated with Uvei
Oct 21, 2021 07:02AM Bausch Health Co. Inc. (BHC) Appoints Tom Vadaketh as CFO
Oct 21, 2021 07:00AM Bausch Health Announces Tom Vadaketh Will Join Bausch Pharma* As Chief Financial Officer
Oct 19, 2021 07:00AM Ortho Dermatologics To Present New Data At The 2021 Fall Clinical Dermatology Conference
Oct 6, 2021 07:00AM Bausch Health Companies Inc. Will Release Third-Quarter 2021 Financial Results On November 2
Sep 30, 2021 07:00AM Bausch + Lomb (BHC) Announces Statistically Significant Topline Results from Second Phase 3 Trial Of NOV03 in Dry Eye Disease Associated with Meibomian Gland Dysfunction
Sep 30, 2021 06:59AM Bausch + Lomb Announces Statistically Significant Topline Results from the Second Phase 3 Trial Of NOV03 (perfluorohexyloctane) in Dry Eye Disease Associated with Meibomian Gland Dysfunction
Sep 29, 2021 07:00AM Bausch Health Releases Annual Environmental, Social and Governance Report
Sep 28, 2021 08:03AM Salix Will Share RELISTOR® (Methylnaltrexone Bromide) Data At The American Society For Pain Management Nursing (ASPMN) 31st National Conference
Sep 2, 2021 07:00AM Salix Will Share RELISTOR® (Methylnaltrexone Bromide) Data At PAINWeek 2021
Sep 1, 2021 07:00AM Bausch Health Announces Participation In Upcoming Investor Conferences
Aug 3, 2021 06:59AM Bausch Health Companies Inc. Announces Second-Quarter 2021 Results
Aug 3, 2021 06:45AM Bausch Health To Reduce Debt By $350 Million
Aug 2, 2021 07:00AM Bausch Health Completes Sale Of Amoun Pharmaceutical To ADQ
Jul 29, 2021 07:00AM Ortho Dermatologics Announces 2021 Aspire Higher Scholarship Recipients
Jul 22, 2021 07:00AM Salix Announces 2021 Gastrointestinal Health Scholars Program Winners
Jul 19, 2021 06:59AM Bausch + Lomb Will Present 14 Scientific Posters Featuring New Analyses Involving Its Surgical Technologies At The 2021 Annual Meeting Of The American Society Of Cataract And Refractive Surgery
Jul 12, 2021 06:59AM Bausch + Lomb Launches Biotrue® Hydration Boost Lubricant Eye Drops and Biotrue® Micellar Eyelid Cleansing Wipes
Jul 7, 2021 06:59AM Bausch + Lomb Completes Enrollment Of Second Phase 3 Study For NOV03 (perfluorohexyloctane)
Jul 6, 2021 07:00AM Bausch Health Companies Inc. Will Release Second-Quarter 2021 Financial Results On August 3
Jul 1, 2021 07:02AM Bausch Health Co. Inc. (BHC) Plans to Reduce Debt by $150M
Jul 1, 2021 07:00AM Bausch Health To Reduce Debt By $150 Million Using Cash Generated From Operations
Jun 23, 2021 07:00AM Bausch + Lomb Expands Parameters for Bausch + Lomb ULTRA® Multifocal for Astigmatism Contact Lenses
Jun 21, 2021 07:14AM Bausch Health Co. Inc. (BHC) Announces D. Robert Hale Has Resigned From Its Board Of Directors
Jun 21, 2021 07:00AM Bausch Health Announces D. Robert Hale Has Resigned From Its Board Of Directors
Jun 15, 2021 08:02AM Salix Will Share TRULANCE® (Plecanatide) Data At The 2021 AANP National Conference
Jun 8, 2021 07:19AM Bausch Health Co. Inc. (BHC), Lochan Enter Into Agreement to Develop Next-Generation of eyeTELLIGENCE Clinical Decision Support Software
Jun 8, 2021 06:59AM Bausch + Lomb and Lochan Enter Into Agreement to Develop the Next-Generation of eyeTELLIGENCE™ Clinical Decision Support Software
Jun 3, 2021 08:02AM Salix Will Share RELISTOR® (Methylnaltrexone Bromide) Data Analysis at the 2021 American Society of Clinical Oncology Annual Meeting and 2021 Annual Meeting of the Multinational Association of Suppor
View More Recent Stories View Older Stories